Clinical Implications of Residual Urine in Korean Benign Prostatic Hyperplasia (BPH) Patients: A Prognostic Factor for BPH-Related Clinical Events.
- Author:
Young Hwii KO
1
;
Ji Yun CHAE
;
Seung Min JEONG
;
Jae Il KANG
;
Hong Jae AHN
;
Hyung Woo KIM
;
Sung Gu KANG
;
Hoon Ah JANG
;
Jun CHEON
;
Je Jong KIM
;
Jeong Gu LEE
Author Information
1. Department of Urology, Korea University School of Medicine, Seoul, Korea. jeongkl@kumc.or.kr
- Publication Type:Original Article
- Keywords:
Benign prostatic hyperplasia;
Disease progression;
Residual urine
- MeSH:
Ambulatory Care Facilities;
Disease Progression;
Dissent and Disputes;
Humans;
Multivariate Analysis;
Prostate;
Prostatic Hyperplasia;
Urinary Retention;
Urinary Tract Infections
- From:International Neurourology Journal
2010;14(4):238-244
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Although post-void residual urine (PVR) is frequently utilized clinically in patients with benign prostatic hyperplasia (BPH), mainly because of its procedural simplicity, its role as a clinical prognostic factor, predictive of treatment goals, is still under much dispute. We investigated the predictive value of PVR for BPH-related clinical events including surgery, acute urinary retention (AUR), and admission following urinary tract infection (UTI). METHODS: From January to June of 2006, patients over 50 years of age who were diagnosed with BPH for the first time at the outpatient clinic and were then treated for at least 3 years with medications were enrolled in this study. The variables of patients who underwent surgical intervention for BPH, had occurrences of AUR, or required admission due to UTI (Group 1, n=43) were compared with those of patients who were maintained with medications only (Group 2, n=266). RESULTS: Group 1 had a significantly higher PVR, more severe symptoms, and a larger prostate at the time of the initial diagnosis in both the univariate and the multivariate analysis. In the 39 patients who underwent BPH-related surgery, although there was a significant change in Qmax at the time of surgery (mean, 13.1 months), PVR and the symptom score remained unchanged compared with the initial evaluation. In the receiver-operating characteristic curve analysis, the area under the curve of Group 1 was in the order of prostate volume (0.834), PVR (0.712), and symptom score (0.621). When redivided by arbitrarily selected PVR cutoffs of 50 mL, 100 mL, and 150 mL, the relative risk of clinical BPH progression was measured as 3.93, 2.61, and 2.11. CONCLUSIONS: These data indicate that, in the symptomatic Korean population, increased PVR at baseline is a significant indicator of BPH-related clinical events along with increased symptom score or prostate volume.
